Table 1 Demographic and clinical characteristics of the group of 29 patients with resistant Social Anxiety Disorder (SAD) enrolled in the study.
From: Resistant social anxiety disorder response to Escitalopram
Age | m: 34.6 sd: 9.9 (range 24–42) |  |
Gender | 13 M (44.8%)/16 F (55.2%) | Â |
Education level (yrs) | m: 12.3 sd: 4.6 | Â |
Marital status | Single n = 9 (31%) | Â |
| Â | Married n = 16 (55.2%) | Â |
| Â | Divorced n = 4 (13.8%) | Â |
Duration of SAD (yrs) | m: 12.9 sd: 7.3 | Â |
Baseline LSAS score | m: 62.4 sd: 10.6 | Â |
Baseline HSRD score | m: 12.68 sd: 2.42 | Â |
Baseline CGI-S | m: 4.8 sd: 1.1 | Â |
CGI-I (Paroxetine trial) | m: 4.3 sd: 0.5 | Â |
Baseline SDS Work | m: 7.6 sd: 1.8 | Â |
Baseline SDS Social | m: 8.5 sd: 2.0 | Â |
Baseline SDS Family | m: 5.2 sd: 1.3 | Â |
Baseline ASEX | m: 19.4 sd: 2.3 | Â |
Lifetime comorbidity | Â | Â |
   Axis I | Depressive disorder | 5 (17.2%) |
| Â | Cyclothimia | 2 (6.9%) |
| Â | Panic disorder | 6 (20.7%) |
| Â | Somatoform disorder | 3 (10.3%) |
| Â | Obsessive-Compulsive Dis. | 2 (6.9%) |
| Â | Alcohol abuse | 5 (17.2%) |
| Â | Substance abuse | 2 (6.9%) |
   Axis 2 | Avoidant PD | 4 (13.8%) |
| Â | Obsessive-Compulsive PD | 1 (3.4%) |
| Â | Passive-Aggressive PD | 1 (3.4%) |
| Â | Narcissistic PD | 1 (3.4%) |